Social media

Long‑acting injectables have reshaped HIV treatment, but they still fall short of overcoming the fundamental limitations of ART. Our latest article explores how next‑generation approaches are moving us closer to the poss...

Long‑acting injectables have reshaped HIV treatment, but they still fall short of overcoming the fundamental limitations of ART. Our latest article explores how next‑generation approaches are moving us closer to the poss...

At ICON, Study Start Up teams play a critical role in accelerating timelines, from site identification and feasibility through to contracting and activation. In this blog, James Pereira shares how leadership in start up...

At ICON, Study Start Up teams play a critical role in accelerating timelines, from site identification and feasibility through to contracting and activation. In this blog, James Pereira shares how leadership in start up...

Attending the World Vaccine Congress? Join ICON’s Dinah Knotts-Keeterle as she discusses ‘AI and the future of vaccine studies from reaction to readiness’. Learn more on 1 April at 12:10 pm. https://ow.ly/9Uk050Yr8VL

With ADC innovation accelerating across Asia, Europe and the US, regulatory synchronisation has never been more important. ICON’s latest article in BioSpectrum Asia explores why proactive scientific advice, dose optimis...

From early scientific advice to accelerated review programmes, strategic regulatory planning is essential for efficient ADC development. ICON’s latest feature explores how global agencies are approaching these hybrid mo...

At #DIAEurope2026 on 25 March from 03:00 pm to 04:10 pm, Dr. Anne Behringer will present virtually on ‘Cross-Border Recruitment in Clinical Trials: A Perspective on Operational Reality’. Discover more. https://ow.ly/ZXk7...

At #DIAEurope2026 on 25 March from 03:00 pm to 04:10 pm, Dr. Anne Behringer will present virtually on ‘Cross-Border Recruitment in Clinical Trials: A Perspective on Operational Reality’. Discover more. https://ow.ly/Rmaf...

On 30 March - 2 April at World Vaccine Congress, meet ICON experts at booth #222 to learn about our 30+ years of experience supporting vaccine development for biotech, pharma, government, and NGOs. https://ow.ly/GzT350Yr...

Attending the GLP-1-Based Therapeutics Summit in Boston? On 15 April at 12:00 pm, ICON’s Alan Baldridge will be presenting, “Is there anything GLP‑1s can’t do? Unlocking the next generation of metabolic treatments.” He’...

Human ADME studies are essential for understanding how investigational drugs are absorbed, distributed, metabolised and excreted. Yet traditional sampling—limited to plasma, urine and faeces- leaves a key blind spot: bil...